Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
εPA-44 in Chronic Hepatitis B
NCT00869778Phase 2Completed
- Sponsor
- Chongqing Jiachen Biotechnology Ltd.
- Start
- Apr 2009
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic HBV vaccine in Chronic Hepatitis B (CHB), sponsored by Chongqing Jiachen Biotechnology Ltd.. Started Apr 2009; status: completed.
02
Drugs
therapeutic HBV vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00869778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869778.